Evotec to Acquire Aptuit, Expanding Leadership in External Innovation

We are pleased to share the press release published today about the agreement between Evotec AG and Aptuit under which Evotec will acquire Aptuit.

Topics: Acquisition, Corporate, Contract Reseach Organization, Drug Discovery, Drug Development, Integrated CMC, IND Enabling, Partner Research Organization Read More

Why We Need a Culture of International Collaboration to Fight Antibiotic Resistance

Read the article on antimicrobial resistance from our very own Antonio Felici, which was published in Bioscience Technology this month. Read full article from Bioscience Technology online site

Topics: Antibiotic Resistance, Drug Discovery, Drug design and discovery Read More

Bioversys AG and Aptuit Announce Collaboration to Identify Novel Approaches to Treat Serious Infections from Gram-negative Pathogens

Basel, Switzerland and Greenwich, CT – March 7, 2017 - Bioversys AG and Aptuit today announced the start of a joint collaboration aimed at the identification and validation of novel targets and molecules for Gram-negative bacteria. Aptuit and BioVersys hope that innovative approaches can address ...

Topics: Drug Discovery, Drug design and discovery, Gram-negative bacteria, Antibiotic Resistance, Partner Research Organization Read More

Dementia Discovery Fund Acquires Small Molecule Library and Enters Strategic Partnership with Aptuit to Kickstart Dementia Drug Discovery Programmes

The Dementia Discovery Fund announces the acquisition of a >500,000 compound, CNS-biased small molecule library The DDF and Aptuit enter into a strategic partnership to leverage the DDF library and Aptuit’s capabilities for dementia drug discovery London, Boston, Greenwich - February 28, 2017 – The ...

Topics: Drug Discovery, Drug design and discovery, Dementia Drug Discovery, Computational Chemistry, Compound Logistics, Assay Development, Hit Discovery Read More

Most Read

Posts by Topic